MISTY TAYLOR: Open Payments
NPI 1316223019 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 75 payments from 20 companies in 2025. Trend: 2023 $467 · 2024 $1,324 · 2025 $1,517
Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $307 |
| PFIZER INC. | 9 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $154 |
| AstraZeneca Pharmaceuticals LP | 3 | $139 |
| Corcept Therapeutics | 4 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Exact Sciences Corporation | 4 | $87 |
| Novo Nordisk Inc | 4 | $87 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
Products named: VRAYLAR, Kerendia, Korlym, AIRSUPRA, JARDIANCE, PREVNAR 20, The Cologuard Plus Collection Kit, QULIPTA.
Industry payments across TX — which companies pay providers there.
